AustralieFrV1, Ncbi, Merge, bibRecord, 001A58

Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer.

Identifieur interne : 001A58 ( Ncbi/Merge ); précédent : 001A57; suivant : 001A59

Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer.

Auteurs : Damien C. Weber [Belgique] ; Coen W. Hurkmans [Pays-Bas] ; Christos Melidis [Belgique] ; Wilfried Budach [Allemagne] ; Johannes H. Langendijk [Pays-Bas] ; Lester J. Peters [Australie] ; Vincent Grégoire [Belgique] ; Philippe Maingon [France] ; Christophe Combescure [Suisse]

Source :

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [ 1879-0887 ] ; 2014.

RBID : pubmed:24861631

Descripteurs français

English descriptors

Abstract

One of the goals of Quality Assurance in Radiotherapy (QART) is to reduce the variability and uncertainties related to treatment planning and beam delivery. The purpose of this study was to assess the outcome impact and cost-effectiveness (CE) of various QART levels for a head and neck (H&N) cancer study.

DOI: 10.1016/j.radonc.2014.04.015
PubMed: 24861631

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 003738
to stream PubMed, to step Curation: 003624
to stream PubMed, to step Checkpoint: 003624

Links to Exploration step

pubmed:24861631

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer.</title>
<author><name sortKey="Weber, Damien C" sort="Weber, Damien C" uniqKey="Weber D" first="Damien C" last="Weber">Damien C. Weber</name>
<affiliation wicri:level="3"><nlm:affiliation>Center for Proton Therapy, Paul Scherrer Institute, Switzerland; QA Strategic Committee and Team, EORTC HQ, Brussels, Belgium. Electronic address: damien.weber@psi.ch.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Center for Proton Therapy, Paul Scherrer Institute, Switzerland; QA Strategic Committee and Team, EORTC HQ, Brussels</wicri:regionArea>
<placeName><settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hurkmans, Coen W" sort="Hurkmans, Coen W" uniqKey="Hurkmans C" first="Coen W" last="Hurkmans">Coen W. Hurkmans</name>
<affiliation wicri:level="1"><nlm:affiliation>QA Strategic Committee and Team, EORTC HQ, Brussels, Belgium; Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands. Electronic address: coen.hurkmans@catharinaziekenhuis.nl.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>QA Strategic Committee and Team, EORTC HQ, Brussels, Belgium; Radiation Oncology, Catharina Hospital, Eindhoven</wicri:regionArea>
<wicri:noRegion>Eindhoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Melidis, Christos" sort="Melidis, Christos" uniqKey="Melidis C" first="Christos" last="Melidis">Christos Melidis</name>
<affiliation wicri:level="3"><nlm:affiliation>QA Strategic Committee and Team, EORTC HQ, Brussels, Belgium. Electronic address: christos.melidis@eortc.be.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>QA Strategic Committee and Team, EORTC HQ, Brussels</wicri:regionArea>
<placeName><settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Budach, Wilfried" sort="Budach, Wilfried" uniqKey="Budach W" first="Wilfried" last="Budach">Wilfried Budach</name>
<affiliation wicri:level="1"><nlm:affiliation>Heinrich-Heine Universitätsklinik Düsseldorf, Germany. Electronic address: Wilfried.Budach@med.uni-duesseldorf.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Heinrich-Heine Universitätsklinik Düsseldorf</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Langendijk, Johannes H" sort="Langendijk, Johannes H" uniqKey="Langendijk J" first="Johannes H" last="Langendijk">Johannes H. Langendijk</name>
<affiliation wicri:level="1"><nlm:affiliation>University Medical Center Groningen, The Netherlands. Electronic address: j.a.langendijk@umcg.nl.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>University Medical Center Groningen</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Peters, Lester J" sort="Peters, Lester J" uniqKey="Peters L" first="Lester J" last="Peters">Lester J. Peters</name>
<affiliation wicri:level="3"><nlm:affiliation>Peter MacCallum Cancer Centre, Melbourne, Australia. Electronic address: Lester.Peters@petermac.org.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Peter MacCallum Cancer Centre, Melbourne</wicri:regionArea>
<placeName><settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gregoire, Vincent" sort="Gregoire, Vincent" uniqKey="Gregoire V" first="Vincent" last="Grégoire">Vincent Grégoire</name>
<affiliation wicri:level="3"><nlm:affiliation>St. Luc University Hospital, Brussels, Belgium. Electronic address: vincent.gregoire@imre.ucl.ac.be.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>St. Luc University Hospital, Brussels</wicri:regionArea>
<placeName><settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Maingon, Philippe" sort="Maingon, Philippe" uniqKey="Maingon P" first="Philippe" last="Maingon">Philippe Maingon</name>
<affiliation wicri:level="3"><nlm:affiliation>Radiation Oncology, Centre Georges-François-Leclerc, Dijon, France. Electronic address: pmaingon@dijon.fnclcc.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Radiation Oncology, Centre Georges-François-Leclerc, Dijon</wicri:regionArea>
<placeName><region type="region">Bourgogne-Franche-Comté</region>
<region type="old region">Bourgogne</region>
<settlement type="city">Dijon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Combescure, Christophe" sort="Combescure, Christophe" uniqKey="Combescure C" first="Christophe" last="Combescure">Christophe Combescure</name>
<affiliation wicri:level="1"><nlm:affiliation>Clinical Epidemiology, Department of Health and Community Medicine, University Hospitals of Geneva, Switzerland. Electronic address: christophe.combescure@hcuge.ch.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Clinical Epidemiology, Department of Health and Community Medicine, University Hospitals of Geneva</wicri:regionArea>
<wicri:noRegion>University Hospitals of Geneva</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24861631</idno>
<idno type="pmid">24861631</idno>
<idno type="doi">10.1016/j.radonc.2014.04.015</idno>
<idno type="wicri:Area/PubMed/Corpus">003738</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003738</idno>
<idno type="wicri:Area/PubMed/Curation">003624</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003624</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003624</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003624</idno>
<idno type="wicri:Area/Ncbi/Merge">001A58</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer.</title>
<author><name sortKey="Weber, Damien C" sort="Weber, Damien C" uniqKey="Weber D" first="Damien C" last="Weber">Damien C. Weber</name>
<affiliation wicri:level="3"><nlm:affiliation>Center for Proton Therapy, Paul Scherrer Institute, Switzerland; QA Strategic Committee and Team, EORTC HQ, Brussels, Belgium. Electronic address: damien.weber@psi.ch.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Center for Proton Therapy, Paul Scherrer Institute, Switzerland; QA Strategic Committee and Team, EORTC HQ, Brussels</wicri:regionArea>
<placeName><settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hurkmans, Coen W" sort="Hurkmans, Coen W" uniqKey="Hurkmans C" first="Coen W" last="Hurkmans">Coen W. Hurkmans</name>
<affiliation wicri:level="1"><nlm:affiliation>QA Strategic Committee and Team, EORTC HQ, Brussels, Belgium; Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands. Electronic address: coen.hurkmans@catharinaziekenhuis.nl.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>QA Strategic Committee and Team, EORTC HQ, Brussels, Belgium; Radiation Oncology, Catharina Hospital, Eindhoven</wicri:regionArea>
<wicri:noRegion>Eindhoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Melidis, Christos" sort="Melidis, Christos" uniqKey="Melidis C" first="Christos" last="Melidis">Christos Melidis</name>
<affiliation wicri:level="3"><nlm:affiliation>QA Strategic Committee and Team, EORTC HQ, Brussels, Belgium. Electronic address: christos.melidis@eortc.be.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>QA Strategic Committee and Team, EORTC HQ, Brussels</wicri:regionArea>
<placeName><settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Budach, Wilfried" sort="Budach, Wilfried" uniqKey="Budach W" first="Wilfried" last="Budach">Wilfried Budach</name>
<affiliation wicri:level="1"><nlm:affiliation>Heinrich-Heine Universitätsklinik Düsseldorf, Germany. Electronic address: Wilfried.Budach@med.uni-duesseldorf.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Heinrich-Heine Universitätsklinik Düsseldorf</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Langendijk, Johannes H" sort="Langendijk, Johannes H" uniqKey="Langendijk J" first="Johannes H" last="Langendijk">Johannes H. Langendijk</name>
<affiliation wicri:level="1"><nlm:affiliation>University Medical Center Groningen, The Netherlands. Electronic address: j.a.langendijk@umcg.nl.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>University Medical Center Groningen</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Peters, Lester J" sort="Peters, Lester J" uniqKey="Peters L" first="Lester J" last="Peters">Lester J. Peters</name>
<affiliation wicri:level="3"><nlm:affiliation>Peter MacCallum Cancer Centre, Melbourne, Australia. Electronic address: Lester.Peters@petermac.org.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Peter MacCallum Cancer Centre, Melbourne</wicri:regionArea>
<placeName><settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gregoire, Vincent" sort="Gregoire, Vincent" uniqKey="Gregoire V" first="Vincent" last="Grégoire">Vincent Grégoire</name>
<affiliation wicri:level="3"><nlm:affiliation>St. Luc University Hospital, Brussels, Belgium. Electronic address: vincent.gregoire@imre.ucl.ac.be.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>St. Luc University Hospital, Brussels</wicri:regionArea>
<placeName><settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Maingon, Philippe" sort="Maingon, Philippe" uniqKey="Maingon P" first="Philippe" last="Maingon">Philippe Maingon</name>
<affiliation wicri:level="3"><nlm:affiliation>Radiation Oncology, Centre Georges-François-Leclerc, Dijon, France. Electronic address: pmaingon@dijon.fnclcc.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Radiation Oncology, Centre Georges-François-Leclerc, Dijon</wicri:regionArea>
<placeName><region type="region">Bourgogne-Franche-Comté</region>
<region type="old region">Bourgogne</region>
<settlement type="city">Dijon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Combescure, Christophe" sort="Combescure, Christophe" uniqKey="Combescure C" first="Christophe" last="Combescure">Christophe Combescure</name>
<affiliation wicri:level="1"><nlm:affiliation>Clinical Epidemiology, Department of Health and Community Medicine, University Hospitals of Geneva, Switzerland. Electronic address: christophe.combescure@hcuge.ch.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Clinical Epidemiology, Department of Health and Community Medicine, University Hospitals of Geneva</wicri:regionArea>
<wicri:noRegion>University Hospitals of Geneva</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</title>
<idno type="eISSN">1879-0887</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Carcinoma, Squamous Cell (economics)</term>
<term>Carcinoma, Squamous Cell (radiotherapy)</term>
<term>Cohort Studies</term>
<term>Cost-Benefit Analysis</term>
<term>Head and Neck Neoplasms (economics)</term>
<term>Head and Neck Neoplasms (radiotherapy)</term>
<term>Humans</term>
<term>Models, Statistical</term>
<term>Prospective Studies</term>
<term>Quality Assurance, Health Care</term>
<term>Quality-Adjusted Life Years</term>
<term>Radiotherapy Planning, Computer-Assisted (economics)</term>
<term>Radiotherapy Planning, Computer-Assisted (methods)</term>
<term>Radiotherapy Planning, Computer-Assisted (standards)</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Analyse coût-bénéfice</term>
<term>Années de vie ajustées sur la qualité</term>
<term>Assurance de la qualité des soins de santé</term>
<term>Carcinome épidermoïde (radiothérapie)</term>
<term>Carcinome épidermoïde (économie)</term>
<term>Humains</term>
<term>Modèles statistiques</term>
<term>Planification de radiothérapie assistée par ordinateur ()</term>
<term>Planification de radiothérapie assistée par ordinateur (normes)</term>
<term>Planification de radiothérapie assistée par ordinateur (économie)</term>
<term>Résultat thérapeutique</term>
<term>Tumeurs de la tête et du cou (radiothérapie)</term>
<term>Tumeurs de la tête et du cou (économie)</term>
<term>Études de cohortes</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Carcinoma, Squamous Cell</term>
<term>Head and Neck Neoplasms</term>
<term>Radiotherapy Planning, Computer-Assisted</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Radiotherapy Planning, Computer-Assisted</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Planification de radiothérapie assistée par ordinateur</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Carcinoma, Squamous Cell</term>
<term>Head and Neck Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Carcinome épidermoïde</term>
<term>Tumeurs de la tête et du cou</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Radiotherapy Planning, Computer-Assisted</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Carcinome épidermoïde</term>
<term>Planification de radiothérapie assistée par ordinateur</term>
<term>Tumeurs de la tête et du cou</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Cohort Studies</term>
<term>Cost-Benefit Analysis</term>
<term>Humans</term>
<term>Models, Statistical</term>
<term>Prospective Studies</term>
<term>Quality Assurance, Health Care</term>
<term>Quality-Adjusted Life Years</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Analyse coût-bénéfice</term>
<term>Années de vie ajustées sur la qualité</term>
<term>Assurance de la qualité des soins de santé</term>
<term>Humains</term>
<term>Modèles statistiques</term>
<term>Planification de radiothérapie assistée par ordinateur</term>
<term>Résultat thérapeutique</term>
<term>Études de cohortes</term>
<term>Études prospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">One of the goals of Quality Assurance in Radiotherapy (QART) is to reduce the variability and uncertainties related to treatment planning and beam delivery. The purpose of this study was to assess the outcome impact and cost-effectiveness (CE) of various QART levels for a head and neck (H&N) cancer study.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24861631</PMID>
<DateCreated><Year>2014</Year>
<Month>08</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted><Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>08</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0887</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>111</Volume>
<Issue>3</Issue>
<PubDate><Year>2014</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</Title>
<ISOAbbreviation>Radiother Oncol</ISOAbbreviation>
</Journal>
<ArticleTitle>Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer.</ArticleTitle>
<Pagination><MedlinePgn>393-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.radonc.2014.04.015</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0167-8140(14)00180-7</ELocationID>
<Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">One of the goals of Quality Assurance in Radiotherapy (QART) is to reduce the variability and uncertainties related to treatment planning and beam delivery. The purpose of this study was to assess the outcome impact and cost-effectiveness (CE) of various QART levels for a head and neck (H&N) cancer study.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">QART levels were defined as: basic QART with a dummy run (level 2), level 2 plus prospective Individual Case Reviews (ICRs) for 15% of patients (level 3) and level 2 plus prospective ICRs for all patients (level 4). The follow-up of patients was modeled using a multi-state model with parameters derived from EORTC, TROG and RTOG prospective studies. Individual patient data, linking QART results with outcome, were retrieved from the TROG database. Results for each QART level were expressed as percentage of mortality and local failure at 5 years.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Quality-of-life-adjusted and recurrence-free survival increased with increasing QART levels. The increase of all these metrics was more sizeable with an increased QART level from 2 or 3 to 4. The estimated quality-adjusted-life-years (QALYs) for an increase of QART levels of 3-4 and 2-4 were 0.09 and 0.15, respectively. The incremental CE ratio was €5525 and €3659 Euros per QALY for these QART levels. Compared to QART level 2 or 3, level 4 was cost-effective.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Increasing QART levels resulted in better patient outcome in this simulated study. The increased complexity of the QART program was also cost-effective.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weber</LastName>
<ForeName>Damien C</ForeName>
<Initials>DC</Initials>
<AffiliationInfo><Affiliation>Center for Proton Therapy, Paul Scherrer Institute, Switzerland; QA Strategic Committee and Team, EORTC HQ, Brussels, Belgium. Electronic address: damien.weber@psi.ch.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hurkmans</LastName>
<ForeName>Coen W</ForeName>
<Initials>CW</Initials>
<AffiliationInfo><Affiliation>QA Strategic Committee and Team, EORTC HQ, Brussels, Belgium; Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands. Electronic address: coen.hurkmans@catharinaziekenhuis.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Melidis</LastName>
<ForeName>Christos</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>QA Strategic Committee and Team, EORTC HQ, Brussels, Belgium. Electronic address: christos.melidis@eortc.be.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Budach</LastName>
<ForeName>Wilfried</ForeName>
<Initials>W</Initials>
<AffiliationInfo><Affiliation>Heinrich-Heine Universitätsklinik Düsseldorf, Germany. Electronic address: Wilfried.Budach@med.uni-duesseldorf.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Langendijk</LastName>
<ForeName>Johannes H</ForeName>
<Initials>JH</Initials>
<AffiliationInfo><Affiliation>University Medical Center Groningen, The Netherlands. Electronic address: j.a.langendijk@umcg.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Peters</LastName>
<ForeName>Lester J</ForeName>
<Initials>LJ</Initials>
<AffiliationInfo><Affiliation>Peter MacCallum Cancer Centre, Melbourne, Australia. Electronic address: Lester.Peters@petermac.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Grégoire</LastName>
<ForeName>Vincent</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>St. Luc University Hospital, Brussels, Belgium. Electronic address: vincent.gregoire@imre.ucl.ac.be.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Maingon</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Radiation Oncology, Centre Georges-François-Leclerc, Dijon, France. Electronic address: pmaingon@dijon.fnclcc.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Combescure</LastName>
<ForeName>Christophe</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Clinical Epidemiology, Department of Health and Community Medicine, University Hospitals of Geneva, Switzerland. Electronic address: christophe.combescure@hcuge.ch.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>05</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Ireland</Country>
<MedlineTA>Radiother Oncol</MedlineTA>
<NlmUniqueID>8407192</NlmUniqueID>
<ISSNLinking>0167-8140</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList><SupplMeshName Type="Disease" UI="C535575">Carcinoma, squamous cell of head and neck</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006258" MajorTopicYN="N">Head and Neck Neoplasms</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011785" MajorTopicYN="N">Quality Assurance, Health Care</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019057" MajorTopicYN="N">Quality-Adjusted Life Years</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011880" MajorTopicYN="N">Radiotherapy Planning, Computer-Assisted</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cost-effectiveness</Keyword>
<Keyword MajorTopicYN="N">Head and neck cancer</Keyword>
<Keyword MajorTopicYN="N">Quality assurances</Keyword>
<Keyword MajorTopicYN="N">Quality-adjusted-life-years</Keyword>
<Keyword MajorTopicYN="N">Radiotherapy</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>12</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2014</Year>
<Month>04</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>04</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>5</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>5</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>11</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">24861631</ArticleId>
<ArticleId IdType="pii">S0167-8140(14)00180-7</ArticleId>
<ArticleId IdType="doi">10.1016/j.radonc.2014.04.015</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Allemagne</li>
<li>Australie</li>
<li>Belgique</li>
<li>France</li>
<li>Pays-Bas</li>
<li>Suisse</li>
</country>
<region><li>Bourgogne</li>
<li>Bourgogne-Franche-Comté</li>
<li>Région de Bruxelles-Capitale</li>
<li>Victoria (État)</li>
</region>
<settlement><li>Bruxelles</li>
<li>Dijon</li>
<li>Melbourne</li>
</settlement>
</list>
<tree><country name="Belgique"><region name="Région de Bruxelles-Capitale"><name sortKey="Weber, Damien C" sort="Weber, Damien C" uniqKey="Weber D" first="Damien C" last="Weber">Damien C. Weber</name>
</region>
<name sortKey="Gregoire, Vincent" sort="Gregoire, Vincent" uniqKey="Gregoire V" first="Vincent" last="Grégoire">Vincent Grégoire</name>
<name sortKey="Melidis, Christos" sort="Melidis, Christos" uniqKey="Melidis C" first="Christos" last="Melidis">Christos Melidis</name>
</country>
<country name="Pays-Bas"><noRegion><name sortKey="Hurkmans, Coen W" sort="Hurkmans, Coen W" uniqKey="Hurkmans C" first="Coen W" last="Hurkmans">Coen W. Hurkmans</name>
</noRegion>
<name sortKey="Langendijk, Johannes H" sort="Langendijk, Johannes H" uniqKey="Langendijk J" first="Johannes H" last="Langendijk">Johannes H. Langendijk</name>
</country>
<country name="Allemagne"><noRegion><name sortKey="Budach, Wilfried" sort="Budach, Wilfried" uniqKey="Budach W" first="Wilfried" last="Budach">Wilfried Budach</name>
</noRegion>
</country>
<country name="Australie"><region name="Victoria (État)"><name sortKey="Peters, Lester J" sort="Peters, Lester J" uniqKey="Peters L" first="Lester J" last="Peters">Lester J. Peters</name>
</region>
</country>
<country name="France"><region name="Bourgogne-Franche-Comté"><name sortKey="Maingon, Philippe" sort="Maingon, Philippe" uniqKey="Maingon P" first="Philippe" last="Maingon">Philippe Maingon</name>
</region>
</country>
<country name="Suisse"><noRegion><name sortKey="Combescure, Christophe" sort="Combescure, Christophe" uniqKey="Combescure C" first="Christophe" last="Combescure">Christophe Combescure</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A58 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001A58 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:24861631
   |texte=   Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:24861631" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer.

Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki